hrp0098p2-246 | Pituitary, Neuroendocrinology and Puberty | ESPE2024

The role of insulin-like growth factor-I in predicting growth velocity during GnRH-agonists treatment for central precocious puberty.

Citterio Valeria , Rodari Giulia , Collini Valentina , Risio Alessandro , Comitani Sofia , Profka Eriselda , Giacchetti Federico , Mantovani Giovanna , Giavoli Claudia

Introduction: Central precocious puberty is characterized by early activation of pituitary-gonadal axis, often associated with high levels of insulin-like growth factor-I (IGF-I), together with accelerated growth and bone maturation, which can ultimately lead to a low adult height (HT). Treatment with GnRH-agonists (GnRHa) can help reducing growth acceleration and rate of bone maturation, though not always restoring prepubertal growth velocity. The causes of d...